US Broker Ratings

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Revealing a 11.64% Potential Upside in a Competitive Market

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors. With a market..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring the 50.24% Upside Potential

LifeStance Health Group, Inc. (LFST) is emerging as a compelling player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $2.18 billion, LifeStance..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 17.70% Upside Potential

Alignment Healthcare, Inc. (NASDAQ: ALHC), a burgeoning player in the healthcare sector, is capturing investor interest with its robust growth potential and strategic positioning within the Medicare Advantage market. Based..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a Potential 100% Upside

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, has been capturing investor attention with its robust growth potential and strategic partnerships. With a market capitalization of $1.29..

Structure Therapeutics Inc. (GPCR) Investor Outlook: Unpacking a 250% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is gaining significant traction among investors, and for good reason. With a market capitalization of $1.2 billion, this healthcare player is making waves in the..

Omnicell, Inc. (OMCL) Stock Analysis: Healthcare Innovator Offers 36% Potential Upside

Omnicell, Inc. (OMCL), a prominent player in the healthcare sector specializing in health information services, is drawing attention with a notable potential upside of 36.10%. With a market capitalization of..

Galapagos NV (GLPG) Stock Analysis: Navigating the Biotech Terrain with a 23% Downside Potential

Galapagos NV (GLPG), a prominent player in the biotechnology sector, is headquartered in Mechelen, Belgium, and focuses on developing innovative medicines in oncology and immunology across the United States and..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a Potential 50% Upside in the Healthcare Sector

For investors keen on the healthcare sector, Kestra Medical Technologies, Ltd. (KMTS) represents a compelling opportunity, especially given its innovative approach to cardiovascular health. As a key player in the..

Organon & Co. (OGN) Stock Analysis: Navigating a 25.76% Potential Upside Amidst Market Challenges

Organon & Co. (NYSE: OGN) is a healthcare company that develops and delivers a diverse range of prescription therapies and medical devices globally. With a market capitalization of $2.72 billion,..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Strong Revenue Growth and Analyst Consensus Points to Promising Upside

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is emerging as a noteworthy player in the healthcare sector, specifically within the drug manufacturers – specialty and generic industry. With a market capitalization of..

Amedisys Inc (AMED) Stock Analysis: Insights into Its Healthcare Growth and Analyst Ratings

Amedisys Inc (NASDAQ: AMED), a notable player in the healthcare sector, is carving out a significant niche within the medical care facilities industry. With a market capitalization of $3.32 billion,..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unveiling a 130% Potential Upside in the Biotech Arena

Beam Therapeutics Inc. (NASDAQ: BEAM) is capturing the attention of investors with its promise of a significant potential upside, despite facing challenging financial metrics. Specializing in precision genetic medicines, Beam..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: A 37% Potential Upside Amid Biotech Innovation

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is capturing investor attention with its innovative approach to treating ocular diseases and its potential upside of 37.33%. The company, headquartered in Bedford, Massachusetts, operates..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A Promising 26% Upside in the Biotech Arena

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) has emerged as a notable contender in the biotechnology sector, focusing on innovative dermatological treatments. With a market cap of $2.08 billion, the company has..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 39% Potential Upside

AdaptHealth Corp. (NASDAQ: AHCO) operates within the healthcare sector, specifically in the medical devices industry, and is becoming a noteworthy consideration for investors looking to capitalize on the growing demand..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a Potential 237% Upside in the Biotech Sector

Biohaven Ltd. (NASDAQ: BHVN), a notable player in the biotechnology sector, has captured investor attention with its ambitious pipeline and significant potential upside. With a market cap of $1.53 billion,..

Twist Bioscience Corporation (TWST) Stock Analysis: Unveiling a 52.38% Potential Upside

Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the healthcare sector, is drawing attention with its promising outlook and robust growth potential. Operating in the diagnostics and research industry,..

Liquidia Corporation (LQDA) Stock Analysis: A Biotech with a 31% Potential Upside

Liquidia Corporation (NASDAQ: LQDA), a promising player in the biotechnology sector, has captured investor attention with an impressive potential upside of 31.05%. Specializing in innovative treatments for pulmonary diseases, Liquidia’s..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Discovering a Potential 165% Upside in Biotech Innovation

Dyne Therapeutics, Inc. (NASDAQ: DYN) is making waves in the biotechnology sector with its innovative approach to treating neuromuscular diseases. As a clinical-stage company based in Waltham, Massachusetts, Dyne is..

AtriCure, Inc. (ATRC) Stock Analysis: 38.89% Potential Upside with Strong Buy Ratings

AtriCure, Inc. (NASDAQ: ATRC) stands out as a compelling investment opportunity within the healthcare sector, specifically under the medical instruments and supplies industry. With innovative products targeting cardiac tissue ablation..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds